Aivo

Aivo is a revolutionary chronic pain relief program that utilizes advanced AI technology. It is based on groundbreaking neuroscience and offers a comprehensive approach to treating chronic pain. The program starts with a free assessment and a 7-day trial. It understands that chronic pain has changed the way individuals perceive the world and aims to address the root cause. Aivo combines a multidisciplinary team, including Chief Science Officer Dr. Vania Apkarian, Chief Clinical Officer Dr. Melissa Farmer, and Medical Advisor Outi Hilgert, M.D. The program assesses the entire pain experience and builds a personalized, data-driven, and continuously adapting care plan. It focuses on all aspects of living with chronic pain, including disrupted sleep, physical movement, stress management, and relief learning. Members have reported significant improvements in their quality of life. Aivo is currently available in the United States through the app and is working on international expansion. It is offered as a $59 per month subscription, with most members experiencing marked pain relief within the first 8 weeks. Although not covered by insurance, it accepts FSA/HSA payments. Aivo does not prescribe medications but works either stand-alone or alongside a medication plan, with many members reducing or even eliminating their medication use.